Design of Novel GPR6 Inverse Agonists Using a Fragment Replacement Scaffold Hopping Approach
The orphan G protein coupled receptor 6 (GPR6) is a cannabinoid-related Class A GPCR. It is highly expressed in the central nervous system and exhibits high constitutive activation of adenylyl cyclase. Several research groups have demonstrated that GPR6 represents a possible target for the treatment...
Main Authors: | Israa Isawi, Paula Morales, Dow Hurst, Nadine Jagerovic, Patricia Reggio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/22/1/29 |
Similar Items
-
GPR6 Structural Insights: Homology Model Construction and Docking Studies
by: Israa H. Isawi, et al.
Published: (2020-02-01) -
Free energy perturbation (FEP)-guided scaffold hopping
by: Deyan Wu, et al.
Published: (2022-03-01) -
The Therapeutic Potential of Orphan GPCRs, GPR35 and GPR55
by: Patricia Hodapp Reggio, et al.
Published: (2015-04-01) -
Deep scaffold hopping with multimodal transformer neural networks
by: Shuangjia Zheng, et al.
Published: (2021-11-01) -
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design
by: Joana Magalhães, et al.
Published: (2018-01-01)